The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $34.
Paymentus Holdings, Inc.
PAY · the NYSE · USD · Market cap $4.2B · 1,340 employees
Paymentus Holdings, Inc.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago
Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price34.41 USD at the 13 Nov 2026 close
- Our value readFair vs our fair value, as of 13 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.20)
- Last reviewed13 Nov 2026 (4 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $33.30 to $40.04, base estimate $34.82 (screen dated 2026-11-13).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.20, read 2026-11-14
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Paymentus Holdings, Inc. holds its Markup at $34.41. The statistical read favours the sellers, held for 47 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 47 days |
| Price at the screen | $34.41 |
| Valuation | 45.88 trailing · 30.94 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.38 |
Five Screens, Shown in Full
Does not pass. Accounts receivable
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 1.03% | Below 33% | Interest-bearing debt is just 1.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 63.37% | Below 49% | Money owed to the company is 63.4% of assets, above the 49% limit. | Fail |
| Revenue purity | 0.79% | Below 5% | Only 0.8% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Paymentus Holdings,'s business is fine, but its receivables are about 63% of its assets, well over the ~49% line, so it does not pass on the financial screens.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PAY's ethical verdict changes
Today PAY does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 13 Nov 2026: it trades at roughly a 1% discount to our $34.82 fair value, 19.80% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 1.2% discount to the base estimate.
Third-party analyst targets: 6 covering, consensus Buy. The average target sits +21% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $34.82, with a range of $33.30 to $40.04, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsBill payments need rails that actually work
Picture a household sorting monthly utilities through an app that just works. Paymentus builds the cloud platform that lets billers handle that flow without the usual headaches. Revenue is rising 30 percent, margins sit at 6 percent, and return on equity reaches 14 percent, yet the shares trade almost exactly at our fair value with only a 3 percent margin of safety.
The numbers do not scream opportunity. Forward earnings sit on a 29.4 times multiple while the moat remains unclear and profit margins stay modest for a software business. Analyst targets cluster near 35 dollars on a buy consensus, but the valuation already reflects most of that optimism and leaves little room for error.
Currency swings and execution slips on new biller contracts could quickly erode the thin cushion. The ethical screen clears, yet the overall setup offers no compelling edge at current levels. Analysis, not advice.
| Forward P/E | 30.9xpriced for continued growth |
| Trailing P/E | 45.9xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 0.73 |
| EPS, forward | 1.08 |
| Revenue growth | +19.8%steady growth |
| Profit margin | 6.7%thin but positive margins |
| Return on equity | 16.0%a solid return on shareholder capital |
| FCF yield | 2.86% |
| Debt to equity | 1.47a meaningful debt load worth watching |
| Current ratio | 4.82comfortably covers its short-term bills |
| Beta | 1.38moves a little more than the market |
| Short interest, float | 0.05% |
| 52-week range | 20.11 - 45.31 |
| Market cap | $4.2B |
| Employees | 1,340 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradePAY trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $34.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $34. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $34. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $34. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $34. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $34. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $34. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $34. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (7 analysts) rates it buy, with a mean price target of $34. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Is NTT Inc. - Sponsored ADR (NTTYY) Stock Outpacing Its Business Services Peers This Year? Yahoo Finance · 5d ago
- Is the Options Market Predicting a Spike in Paymentus Stock? Yahoo Finance · 7d ago
- Is Paymentus Holdings (PAY) Undervalued Following Record Q3 Results And Higher Guidance? Yahoo Finance · 11d ago
- Did Raised Guidance Just Shift Paymentus Holdings (PAY) Investment Narrative? Yahoo Finance · 12d ago
- Paymentus to Participate in Upcoming Investor Conferences Yahoo Finance · 12d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $26.67 | -21.2% | · | $789 | -21.2% |
| 2 months | $24.36 | -13.7% | · | $863 | -13.7% |
| 3 months | $24.12 | -12.8% | · | $872 | -12.8% |
| 6 months | $32.92 | -36.1% | · | $639 | -36.1% |
| 1 year | $35.66 | -41.0% | · | $590 | -41.0% |
| 2 years | $19.64 | +7.1% | · | $1,071 | +7.1% |
| 3 years | $10.01 | +110.1% | · | $2,101 | +110.1% |
| 5 years | $30.11 | -30.2% | · | $698 | -30.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever PAY does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.